SCHEMBL32669037

SCHEMBL32669037

CCOC(=CCP(=O)(O)O)OCC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 3/20 0.35
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PPARD Q03181 2/20 0.32
ALOX15 P16050 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SOAT1 P35610 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30
GLO1 Q04760 1/20 0.30
TRPA1 O75762 1/20 0.30
LAP3 P28838 1/20 0.30
FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10959518 0.75 GLO1 (0.42) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL10959515 0.75 GLO1 (0.42) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL29250746 0.74 NPSR1 (0.37) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL18191275 0.71 ALDH1A1 (0.38) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL7543226 0.69 ALDH1A1 (0.38) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL2909032 0.69 FDPS (0.33) HSD17B10LAP3FDPS
SCHEMBL8115684 0.68 MAPT (0.50) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL8123279 0.68 MAPT (0.50) CYP2D6CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL434442 0.67
SCHEMBL9806262 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260036901-A1 ORGANOMETALLIC COMPOSITIONS WITH PHOSPHONATE ADDITIVES FOR EUV PATTERNING INPRIA CORP (US) 2026-02-05 US claimed
WO-2026030433-A1 ORGANOMETALLIC COMPOSITIONS WITH PHOSPHONATE ADDITIVES FOR EUV PATTERNING INPRIA CORPORATION (US) 2026-02-05 WO disclosed
US-20260036901-A1 ORGANOMETALLIC COMPOSITIONS WITH PHOSPHONATE ADDITIVES FOR EUV PATTERNING INPRIA CORP (US) 2026-02-05 US disclosed
US-20260036901-A1 ORGANOMETALLIC COMPOSITIONS WITH PHOSPHONATE ADDITIVES FOR EUV PATTERNING INPRIA CORP (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260036901-A1 ORGANOMETALLIC COMPOSITIONS WITH PHOSPHONATE ADDITIVES FOR EUV PATTERNING ETV6, PHOSPHO1, PHYKPL CYP2D6 1740/4885CYP2C9 1515/4885CYP2C19 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.